melanotan intranasal brain nanotherapeutics for targeting and clinical studies in Parkinson's disease Intranasal drug administration in psychiatry
Intranasal drug administration in psychiatry by Dan Quintana Medium Intranasal drug delivery: The interaction between nanoparticles and the nose to brain pathway ScienceDirect My first media interview about the dangers of Melanotan II (tanning peptide) was 13 years ago. I discuss this again with @abcnews_au here. Thank you Dr @timpiatkowski for sharing your research Frontiers Transnasal brain delivery of nanomedicines for neurodegenerative diseases Melanotan 2 Nasal Spray Polar Peptides Emerging Threat: Melanotan, Repackaging, and Online Sales
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




